Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step.


Journal

Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187

Informations de publication

Date de publication:
09 2022
Historique:
revised: 09 07 2022
received: 03 05 2022
accepted: 09 08 2022
pubmed: 28 8 2022
medline: 17 9 2022
entrez: 27 8 2022
Statut: ppublish

Résumé

Mitral valve prolapse (MVP) is the most frequent valvulopathy with a prevalence of 1.2%-2.4% in general population and it is characterized by a benign course. Although it can be associated with some complications, ventricular arrhythmias (VA) and sudden cardiac death (SCD) as ultimate expressions, are the most worrying. The estimated risk of SCD in MVP is between 0.2% and 1.9% per year including both MVP patients with left ventricular (LV) dysfunction due to severe MR and MVP patients without significant MR. The latter ones constitute a particular phenotype called "malignant MVP" characterized by bileaflet myxomatous prolapse, ECG repolarization abnormalities and complex VAs (c-VAs) with polymorphic/right bundle branch block morphology (RBBB) and LV fibrosis of the papillary muscles (PMs) and inferobasal wall secondary to mechanical stretching visualized as late gadolinium enhancement (LGE) areas by cardiac magnetic resonance (CMR). In MVP, the first diagnostic approach is transthoracic echocardiography (TTE) that defines the presence of mitral annular disjunction (MAD) which seems to be associated with "arrhythmic MVP" (AMVP). From an ECG point of view, AMVP is characterized by frequent premature ventricular contractions (PVCs) arising from one or both PMs, fascicular tissue, and outflow tract, as well as by T-wave inversion in the inferolateral leads. The aim of the present paper is to describe TTE red flags that could identify MVP patients at high risk to develop complex arrhythmias as supported by the corresponding findings of LGE-CMR and anatomy studies. TTE could be a co-partner in phenotyping high-risk arrhythmic MVP patients.

Identifiants

pubmed: 36029124
doi: 10.1111/echo.15439
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1158-1170

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Barlow JB, Pocock WA. The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J. 1963;12:76-77.
Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507-518.
Warth DC, King ME, Cohen JM, Tesoriero VL, Marcus E, Weyman AE. Prevalence of mitral valve prolapse in normal children. J Am Coll Cardiol. 1985;5:1173-1177.
Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 1987;75:756-767.
Nishimura RA, McGoon MD, Shub C, Miller FA, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. New Engl J Med. 1985;313:1305-1309.
Düren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am College Cardiol. 1988;11:42-47.
Narayanan K, Uy-Evanado A, Teodorescu C, et al. Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm. 2016;13:498-503.
Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556-566.
Nascimento R, Freitas A, Teixeira F, et al. Is mitral valve prolapse a congenital or acquired disease? Am J Cardiol. 1997;79:226-227.
Hickey AJ, Wilcken DE. Age and the clinical profile of idiopathic mitral valve prolapse. Br Heart J. 1986;55:582-586.
Flack JM, Kvasnicka JH, Gardin JM, Gidding SS, Manolio TA, Jacobs DR. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study. Am Heart J. 1999;138:486-492.
van Wijngaarden AL, Hiemstra YL, Koopmann TT, et al. Identification of known and unknown genes associated with mitral valve prolapse using an exome slice methodology. J Med Genet. 2020;57:843-850.
Le Tourneau T, Mérot J, Rimbert A, et al. Genetics of syndromic and non-syndromic mitral valve prolapse. Heart. 2018;104:978-984.
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14.
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2021;ehab395.
Sriram CS, Syed FF, Ferguson ME. et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222-230.
Alenazy A, Eltayeb A, Alotaibi MK. et al. Diagnosis of mitral valve prolapse: much more than simple prolapse. Multimodality approach to risk stratification and therapeutic management. J Clin Med. 2022;11:455.
Nalliah CJ, Mahajan R, Elliott AD, et al. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart. 2019;105:144-151.
Perazzolo Marra M, Basso C, De Lazzari M, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016;9:e005030.
Nordhues BD, Siontis KC, Scott CG, et al. Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death. J Cardiovasc Electrophysol. 2016;27:463-468.
Essayagh B, Sabbag A, Antoine C, et al. Presentation and outcome of arrhythmic mitral valve prolapse. J Am Coll Cardiol. 2020;76:637-649.
Delling FN, Aung S, Vittinghoff E, et al. Antemortem and post-mortem characteristics of lethal mitral valve prolapse among all countywide sudden deaths. JACC Clin Electrophysiol. 2021;7:1025-1034.
Giudicessi JR, Maleszewski JJ, Tester DJ, Ackerman MJ. Prevalence and potential genetic determinants of young sudden unexplained death victims with suspected arrhythmogenic mitral valve prolapse syndrome. Heart Rhythm O2. 2021;2:431-438.
Garbi M, Lancellotti P, Sheppard MN. Mitral valve and left ventricular features in malignant mitral valve prolapse. Open Heart. 2018;5:e000925.
Essayagh B, Sabbag A, Antoine C, et al. The mitral annular disjunction of mitral valve prolapse: presentation and outcome. JACC Cardiovasc Imaging. 2021;14:2073-2087.
Dejgaard LA, Skjølsvik ET, Lie ØH, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72:1600-1609.
Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound. 2010;8:53.
Konda T, Tani T, Suganuma N, et al. Mitral annular disjunction in patients with primary severe mitral regurgitation and mitral valve prolapse. Echocardiography. 2020;37:1716-1722.
Mantegazza V, Tamborini G, Muratori M, et al. Mitral annular disjunction in a large cohort of patients with mitral valve prolapse and significant regurgitation. JACC Cardiovasc Imaging. 2019;12:2278-2280.
Constant Dit Beaufils A-L, Huttin O, Jobbe-Duval A, et al. Replacement myocardial fibrosis in patients with mitral valve prolapse. Circulation. 2021;143:1763-1774.
Guenancia C, Pace N, Hossu G, et al. Prevalence and determinants of PVCs originating from the mitral apparatus in patients with MVP. JACC Clin Electrophysiol. 2022;8:526-528.
Kagiyama N, Toki M, Hayashida A, et al. Prolapse volume to prolapse height ratio for differentiating Barlow's disease from fibroelastic deficiency. Circ J. 2017;81:1730-1735.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30:303-371.
Lawrie GM. Barlow disease: simple and complex. J Thorac Cardiovasc Surg. 2015;150:1078-1081.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;143:e72-e227.
Smer A, Nanda NC, Akdogan RE, Elmarzouky ZM, Dulal S. Echocardiographic Evaluation of Mitral Valve Regurgitation. Mini-Invasive Surgery. OAE Publishing Inc.; 2020;4:52.
Delling FN, Rong J, Larson MG, et al. Evolution of mitral valve prolapse: insights from the Framingham heart study. Circulation. 2016;133:1688-1695.
Zuppiroli A, Mori F, Favilli S, et al. Arrhythmias in mitral valve prolapse: relation to anterior mitral leaflet thickening, clinical variables, and color Doppler echocardiographic parameters. Am Heart J. 1994;128:919-927.
Akcay M, Yuce M, Pala S, et al. Anterior mitral valve length is associated with ventricular tachycardia in patients with classical mitral valve prolapse. Pacing Clin Electrophysiol. 2010;33:1224-1230.
Faletra FF, Leo LA, Paiocchi VL, et al. Anatomy of mitral annulus insights from non-invasive imaging techniques. Eur Heart J Cardiovasc Imaging. 2019;20:843-857.
Angelini A, Ho SY, Anderson RH, Becker AE, Davies MJ. Disjunction of the mitral annulus in floppy mitral valve. N Engl J Med. 1988;318:188-189.
Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. N Engl J Med. 1986;314:535-540.
Toh H, Mori S, Izawa Y, et al. Prevalence and extent of mitral annular disjunction in structurally normal hearts: comprehensive 3D analysis using cardiac computed tomography. Eur Heart J Cardiovasc Imaging. 2021;22:614-622.
Enriquez-Sarano M. Mitral annular disjunction: the forgotten component of myxomatous mitral valve disease. JACC Cardiovasc Imaging. 2017;10:1434-1436.
Faletra FF, Leo LA, Paiocchi VL, et al. Morphology of mitral annular disjunction in mitral valve prolapse. J Am Soc Echocardiogr. 2022;35(2):176-186.
Himori K, Abe M, Tatebayashi D, et al. Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension. PLoS One. 2017;12:e0169146.
Kukavica D, Guglielmo M, Baggiano A, et al. Arrhythmic mitral valve prolapse: introducing an era of multimodality imaging-based diagnosis and risk stratification. Diagnostics (Basel). 2021;11:467.
Mantegazza V, Volpato V, Gripari P, et al. Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse. Heart. 2021;107:25-32.
Komoda T, Hetzer R, Oellinger J, et al. Mitral annular flexibility. J Card Surg. 1997;12:102-109.
Salgo IS, Gorman JH, Gorman RC, et al. Effect of annular shape on leaflet curvature in reducing mitral leaflet stress. Circulation. 2002;106:711-717.
Lee AP-W, Hsiung MC, Salgo IS, et al. Quantitative analysis of mitral valve morphology in mitral valve prolapse with real-time 3-dimensional echocardiography: importance of annular saddle shape in the pathogenesis of mitral regurgitation. Circulation. 2013;127:832-841.
Toh H, Mori S, Izawa Y. et al. Varied extent of mitral annular disjunction among cases with different phenotypes of mitral valve prolapse. JACC Case Rep. 2021;3:1251-1257.
Jensen MO, Hagège AA, Otsuji Y, Levine RA, Leducq transatlantic MITRAL network. The unsaddled annulus: biomechanical culprit in mitral valve prolapse? Circulation. 2013;127:766-768.
Mihalatos DG, Mathew ST, Gopal AS, Joseph S, Grimson R, Reichek N. Relationship of mitral annular remodeling to severity of chronic mitral regurgitation. J Am Soc Echocardiogr. 2006;19:76-82.
Scampardonis G, Yang SS, Maranhão V, Goldberg H, Gooch AS. Left ventricular abnormalities in prolapsed mitral leaflet syndrome. Review of eighty-seven cases. Circulation. 1973;48:287-297.
Yun KL, Fann JI, Rayhill SC, et al. Importance of the mitral subvalvular apparatus for left ventricular segmental systolic mechanics. Circulation. 1990;82:IV89-IV104.
Dal-Bianco JP, Levine RA. Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography. Cardiol Clin. 2013;31:151-164.
Lauretta L, Casalino G, Amzulescu M, David-Cojocariu A, Unger P. How to improve tissue Doppler imaging sensitivity to detect the Pickelhaube sign. Eur Heart J Cardiovasc Imaging. 2020;21:746.
Muthukumar L, Rahman F, Jan MF, et al. The pickelhaube sign: novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. JACC Cardiovasc Imaging. 2017;10:1078-1080.
van Wijngaarden SE, Abou R, Hiemstra YL, Ajmone Marsan N, Bax JJ, Delgado V. Regional left ventricular myocardial mechanics in degenerative myxomatous mitral valve disease: a comparison between fibroelastic deficiency and Barlow's disease. JACC Cardiovasc Imaging. 2018;11:1362-1364.
Huttin O, Pierre S, Venner C, et al. Interactions between mitral valve and left ventricle analysed by 2D speckle tracking in patients with mitral valve prolapse: one more piece to the puzzle. Eur Heart J Cardiovasc Imaging. 2017;18:323-331.
Bui AH, Roujol S, Foppa M, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart. 2017;103:204-209.
van Wijngaarden AL, de Riva M, Hiemstra YL, et al. Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation. Heart. 2021;107:411-418.
Ermakov S, Gulhar R, Lim L, et al. Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse. Heart. 2019;105:1063-1069.
John BT, Tamarappoo BK, Titus JL, Edwards WD, Shen W-K, Chugh SS. Global remodeling of the ventricular interstitium in idiopathic myocardial fibrosis and sudden cardiac death. Heart Rhythm. 2004;1:141-149.
Haland TF, Almaas VM, Hasselberg NE, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17:613-621.
Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work. European Heart Journal. 2012;33:724-733.
Loncaric F, Marciniak M, Nunno L, et al. Distribution of myocardial work in arterial hypertension: insights from non-invasive left ventricular pressure-strain relations. Int J Cardiovasc Imaging. 2021;37:145-154.
Haikal M, Alpert MA, Whiting RB, Kelly D. Increased left ventricular mass in idiopathic mitral valve prolapse. Chest. 1982;82:329-333.
Maron BJ, Sherrid MV, Haas TS, Lindberg J, Kitner C, Lesser JR. Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall. Am J Cardiol. 2010;106:750-752.
Zia MI, Valenti V, Cherston C, Criscito M, Uretsky S, Wolff S. Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging. Am J Cardiol. 2012;109:1321-1325.

Auteurs

Olga Vriz (O)

Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Abdulla Eltayeb (A)

Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Irene Landi (I)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Kashif Anwar (K)

Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Ali Alenazy (A)

Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Krassimira Hiristova (K)

Department of Noninvasive Diagnostic Imaging, National Heart Hospital, Sofia, Bulgaria.

Jarek Kasprzak (J)

Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Antonello D'Andrea (A)

Department of Cardiology, Umberto I Hospital, Luigi Vanvitelli University - Nocera Inferiore (ASL Salerno), Caserta, Italy.

Bandar Amro (B)

Heart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Giuseppe Limongelli (G)

Inherited and Rare Cardiovascular Disease Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN dei Colli, Monaldi Hospital, Naples, Italy.

Eduardo Bossone (E)

Azienda Ospedaliera di Rilevanza Nazionale "A. Cardarelli" Hospital, Naples, Italy.

Massimo Imazio (M)

Department of Cardiology, University Hospital Santa Maria della Misericordia, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH